Wang, Xinzhuo
Fargier-Bochaton, Odile
Dipasquale, Giovanna
Laouiti, Mohamed
Kountouri, Melpomeni
Gorobets, Olena http://orcid.org/0000-0003-2589-092X
Nguyen, Nam P.
Miralbell, Raymond http://orcid.org/0000-0001-7013-7553
Vinh-Hung, Vincent http://orcid.org/0000-0002-6403-6120
Funding for this research was provided by:
University of Geneva
Article History
Received: 20 June 2020
Accepted: 16 November 2020
First Online: 8 January 2021
Compliance with ethical guidelines
:
: N. P. Nguyen and V. Vinh-Hung have joint patents for the application of the mean absolute dose deviation, USPTO 62/608,751, WO/2019/014384. G. Dipasquale and Geneva University Hospitals have a patent pending for a prone immobilization device, EP18 206 344.6, 52146/WO. R. Miralbell had research grants from BrainLab and from Varian AG. V. Vinh-Hung had contact with Varian Medical Systems in 2012–2013 for the installation of Varian Pivotal Prone Breast Care at the Radiation Oncology department of the Geneva University Hospitals, Switzerland. The Radiation Oncology Department of the Geneva University Hospitals had a research agreement with Varian Medical Systems. The department received research funding from the Fundació Privada CELLEX. X. Wang, O. Fargier-Bochaton, M. Laouiti, M. Kountouri, and O. Gorobets declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study received approval at the Geneva University Hospitals Institutional Review Board. Informed consent: not applicable; patients signed informed consent to the treatment procedure, but the study was retrospective.